Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661840 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03661840 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 50 participants.
The verdict
NCT03661840, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Acceptance and Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2021-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03661840
The ClinicalTrials.gov registry entry for NCT03661840 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT03661840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03661840 about?
NCT03661840 is a clinical study titled "Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors". A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.
What is the current status of trial NCT03661840?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-12-04. Estimated completion is 2021-03-04.
What interventions are being tested in trial NCT03661840?
The interventions under investigation include: Treatment as Usual (OTHER), Acceptance and Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03661840?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.